Emmanuel Krakaris - 24 Nov 2021 Form 4 Insider Report for Augmedix, Inc.

Role
PRESIDENT, CEO, AND SECRETARY, Director
Signature
/s/ Paul Ginocchio, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
24 Nov 2021
Net transactions value
+$49,763
Form type
4
Filing time
24 Nov 2021, 18:53:48 UTC
Previous filing
01 Nov 2021
Next filing
11 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Purchase $49,763 +15,551 +41% $3.20 53,051 24 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades ranging from $3.20 to $3.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.